TABLE 3.

The hazard risk of hs-CRP (≥0.5 mg/dl) for mortality in patients with MAFLD.

Death	HR (95% CI)	P
All-cause mortality
Univariate	1.559 (1.409–1.724)	<0.001
Model 1	1.414 (1.273–1.571)	<0.001
Model 2	1.421 (1.278–1.580)	<0.001
Model 3	1.394 (1.253–1.551)	<0.001
Cardiovascular mortality
Univariate	1.641 (1.321–2.039)	<0.001
Model 1	1.549 (1.236–1.942)	<0.001
Model 2	1.536 (1.222–1.931)	<0.001
Model 3	1.497 (1.190–1.885)	0.001
Cancer mortality
Univariate	1.392 (1.124–1.724)	0.002
Model 1	1.280 (1.024–1.599)	0.030
Model 2	1.305 (1.043–1.633)	0.020
Model 3	1.290 (1.030–1.615)	0.027

Model 1 adjusted for gender, age (age≥40 years), race, diabetes and hypertension.

Model 2 adjusted for gender, age (age≥40 years), race, diabetes, hypertension, and continuous variable (including Platelet, FPG, triglyceride and ALT).

Model 3 adjusted for gender, age (age≥40 years), race, diabetes, hypertension, continuous variable (including Platelet, FPG, triglyceride and ALT) and FIB-4 scores.